Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 217961, 5 pages
http://dx.doi.org/10.1155/2015/217961
Research Article

Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis

1Pontifical Catholic University of São Paulo, Rua Conde Fco Matarazzo 58, 18030-010 Sorocaba, SP, Brazil
2University of São Paulo, São Paulo, SP, Brazil
3Hospital Sírio-Libanês, São Paulo, SP, Brazil
4Federal University of Uberlândia, MG, Brazil
5Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
6Metropolitan University of Santos, Santos, SP, Brazil
7Demyelinating Diseases Reference Center, Hospital das Clinicas, University of São Paulo, São Paulo, SP, Brazil

Received 11 October 2014; Revised 21 May 2015; Accepted 3 June 2015

Academic Editor: Bernd L. Fiebich

Copyright © 2015 Paulo Diniz da Gama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. S. Compston, C. Confavreux, H. Lassmann et al., McAlpine's Multiple Sclerosis, Elsevier, London, UK, 4th edition, 2006.
  2. A. I. Bhigjee, K. Moodley, and K. Ramkissoon, “Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study,” Multiple Sclerosis, vol. 13, no. 9, pp. 1095–1099, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Debouverie, C. Lebrun, S. Jeannin, S. Pittion-Vouyovitch, T. Roederer, and H. Vespignani, “More severe disability of North Africans vs Europeans with multiple sclerosis in France,” Neurology, vol. 68, no. 1, pp. 29–32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. B. A. C. Cree, O. Khan, D. Bourdette et al., “Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis,” Neurology, vol. 63, no. 11, pp. 2039–2045, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Cardoso, T. Fukuda, J. Pereira et al., “Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil,” Arquivos de Neuro-Psiquiatria, vol. 64, no. 3, pp. 727–730, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. C. H. Polman, S. C. Reingold, G. Edan et al., “Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’,” Annals of Neurology, vol. 58, no. 6, pp. 840–846, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. S. Freedman, E. J. Thompson, F. Deisenhammer et al., “Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis—a consensus statement,” Archives of Neurology, vol. 62, no. 6, pp. 865–870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. H. Miller, B. G. Weinshenker, M. Filippi et al., “Differential diagnosis of suspected multiple sclerosis: a consensus approach,” Multiple Sclerosis, vol. 14, no. 9, pp. 1157–1174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. P. D. Gama, L. R. Machado, J. A. Livramento et al., “Study of oligoclonal bands in cerebrospinal fluid in black patients with multiple sclerosis,” Multiple Sclerosis Journal, vol. 16, no. 10, p. S60, 2011. View at Google Scholar
  10. P. D. da Gama, L. D. R. Machado, J. A. Livramento et al., “Study of oligoclonal bands restricted to the cerebrospinal fluid in multiple sclerosis patients in the city of São Paulo,” Arquivos de Neuro-Psiquiatria, vol. 67, no. 4, pp. 1017–1022, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Lourenco, A. Shirani, J. Saeedi, J. Oger, W. E. Schreiber, and H. Tremlett, “Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression,” Multiple Sclerosis, vol. 19, no. 5, pp. 577–584, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Tintoré, A. Rovira, J. Río et al., “Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?” Neurology, vol. 70, no. 13, pp. 1079–1083, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Ferraro, A. M. Simone, R. Bedin et al., “Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome,” Journal of Neuroimmunology, vol. 257, no. 1-2, pp. 76–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. R. A. Marrie, G. Cutter, T. Tyry, T. Vollmer, and D. Campagnolo, “Does multiple sclerosis-associated disability differ between races?” Neurology, vol. 66, no. 8, pp. 1235–1240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. D. Kaufman, S. K. Johnson, D. Moyer, J. Bivens, and H. J. Norton, “Multiple sclerosis: severity and progression rate in African Americans compared with whites,” The American Journal of Physical Medicine and Rehabilitation, vol. 82, no. 8, pp. 582–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Weinstock-Guttman, L. D. Jacobs, C. M. Brownscheidle et al., “Multiple sclerosis characteristics in African American patients in the New York state multiple sclerosis consortium,” Multiple Sclerosis, vol. 9, no. 3, pp. 293–298, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. R. Rinker II, K. Trinkaus, R. T. Naismith, and A. H. Cross, “Higher IgG index found in African Americans versus Caucasians with multiple sclerosis,” Neurology, vol. 69, no. 1, pp. 68–72, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. I.-L. Mero, M. W. Gustavsen, H. S. Sæther et al., “Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles,” PLoS ONE, vol. 8, no. 3, Article ID e58352, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Goris, I. Pauwels, M. W. Gustavsen et al., “Genetic variants are major determinants of CSF antibody levels in multiple sclerosis,” Brain, vol. 138, pp. 632–643, 2015. View at Google Scholar